Search research articles
Contact Us
Filters
Showing results (221-230 of 264) with videos related to
Page
of 27
Sort By:
Cancer Research
|
December 18, 2003
EphA2 as target of anticancer immunotherapy: identification of HLA-A*0201-restricted epitopes
Pedro M S Alves, Olivier Faure, Stéphanie Graff-Dubois, et al.
Immunogenetics
|
January 1, 1982
Expression of human class I histocompatibility antigens at the surface of DNA-transformed mouse L cells
F A Lemonnier, M Malissen, P Golstein, et al.
AIDS (London, England)
|
August 1, 2009
Design of a HIV-1-derived HLA-B07.02-restricted polyepitope construct
Sylvain Cardinaud, Romain Bouziat, Pierre-Simon Rohrlich, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 1, 1983
Transformation of murine LMTK- cells with purified HLA class I genes. I. Modification of conformation of murine beta 2-microglobulin upon its association with HLA heavy chains
F A Lemonnier, P P Le Bouteiller, B Malissen, et al.
Immunological Reviews
|
July 1, 1985
HLA class I genes: from structure to expression, serology and function
B R Jordan, D Caillol, M Damotte, et al.
The Journal of Infectious Diseases
|
March 10, 2001
Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers
A Ureta-Vidal, C Pique, Z Garcia, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 6, 2004
HLA-A*0201-restricted cytolytic responses to the rtTA transactivator dominant and cryptic epitopes compromise transgene expression induced by the tetracycline on system
F Ginhoux, S Turbant, D A Gross, et al.
International Journal of Cancer
|
February 1, 2000
Novel breast-tumor-associated MUC1-derived peptides: characterization in Db-/- x beta2 microglobulin (beta2m) null mice transgenic for a chimeric HLA-A2.1/Db-beta2 microglobulin single chain
L Carmon, K M El-Shami, A Paz, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 22, 1999
An HLA-A2 polyepitope vaccine for melanoma immunotherapy
L Mateo, J Gardner, Q Chen, et al.
European Journal of Immunology
|
October 10, 2001
Design of a polyepitope construct for the induction of HLA-A0201-restricted HIV 1-specific CTL responses using HLA-A*0201 transgenic, H-2 class I KO mice
H Firat, S Tourdot, A Ureta-Vidal, et al.
Page
of 27
Search research articles
Search
Showing results (221-230 of 264) with videos related to
Sort By:
Page
of 27
Cancer Research
|
December 18, 2003
EphA2 as target of anticancer immunotherapy: identification of HLA-A*0201-restricted epitopes
Pedro M S Alves, Olivier Faure, Stéphanie Graff-Dubois, et al.
Immunogenetics
|
January 1, 1982
Expression of human class I histocompatibility antigens at the surface of DNA-transformed mouse L cells
F A Lemonnier, M Malissen, P Golstein, et al.
AIDS (London, England)
|
August 1, 2009
Design of a HIV-1-derived HLA-B07.02-restricted polyepitope construct
Sylvain Cardinaud, Romain Bouziat, Pierre-Simon Rohrlich, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 1, 1983
Transformation of murine LMTK- cells with purified HLA class I genes. I. Modification of conformation of murine beta 2-microglobulin upon its association with HLA heavy chains
F A Lemonnier, P P Le Bouteiller, B Malissen, et al.
Immunological Reviews
|
July 1, 1985
HLA class I genes: from structure to expression, serology and function
B R Jordan, D Caillol, M Damotte, et al.
The Journal of Infectious Diseases
|
March 10, 2001
Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers
A Ureta-Vidal, C Pique, Z Garcia, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 6, 2004
HLA-A*0201-restricted cytolytic responses to the rtTA transactivator dominant and cryptic epitopes compromise transgene expression induced by the tetracycline on system
F Ginhoux, S Turbant, D A Gross, et al.
International Journal of Cancer
|
February 1, 2000
Novel breast-tumor-associated MUC1-derived peptides: characterization in Db-/- x beta2 microglobulin (beta2m) null mice transgenic for a chimeric HLA-A2.1/Db-beta2 microglobulin single chain
L Carmon, K M El-Shami, A Paz, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 22, 1999
An HLA-A2 polyepitope vaccine for melanoma immunotherapy
L Mateo, J Gardner, Q Chen, et al.
European Journal of Immunology
|
October 10, 2001
Design of a polyepitope construct for the induction of HLA-A0201-restricted HIV 1-specific CTL responses using HLA-A*0201 transgenic, H-2 class I KO mice
H Firat, S Tourdot, A Ureta-Vidal, et al.
Page
of 27